Ashton Thomas Private Wealth, LLC Novavax Inc Transaction History
Ashton Thomas Private Wealth, LLC
- $4.1 Trillion
- Q4 2025
A detailed history of Ashton Thomas Private Wealth, LLC transactions in Novavax Inc stock. As of the latest transaction made, Ashton Thomas Private Wealth, LLC holds 40,571 shares of NVAX stock, worth $282,779. This represents 0.01% of its overall portfolio holdings.
Number of Shares
40,571
Previous 41,138
1.38%
Holding current value
$282,779
Previous $357 Million
23.56%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding NVAX
# of Institutions
307Shares Held
100MCall Options Held
5.7MPut Options Held
9.03M-
Vanguard Group Inc Valley Forge, PA15.5MShares$108 Million0.0% of portfolio
-
Shah Capital Management14.6MShares$101 Million48.17% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$82.6 Million0.0% of portfolio
-
State Street Corp Boston, MA7.2MShares$50.2 Million0.0% of portfolio
-
Ubs Group Ag4.89MShares$34.1 Million0.01% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $545M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...